Parent Terms |
Term With Siblings |
Child Terms |
|
(2S)-2-(4-\{[(1R,2S)-2-hydroxycyclopentyl]methyl\}phenyl)propanoic acid
(S)-fenfluramine hydrochloride
1-(3-(trifluoromethyl)phenyl)piperazine +
1-(3-chlorophenyl)piperazine
4-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)pyrrolo[1,2-a]quinoxaline +
4-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)pyrrolo[1,2-a]quinoxaline dimaleate
4-(methylamino)antipyrine
4-fluoro-N-\{2-[4-(7-methoxynaphthalen-1-yl)piperazin-1-yl]ethyl\}benzamide
4-fluoro-N-\{2-[4-(7-methoxynaphthalen-1-yl)piperazin-1-yl]ethyl\}benzamide hydrochloride
5-methyltryptamine hydrochloride
5-nonyloxytryptamine oxalate
8-epi-prostaglandin F2alpha +
alpha-methylnoradrenaline
bromfenac sodium salt sesquihydrate
carbocyclic thromboxane A2 +
chlorprothixene hydrochloride
Delta(9)-tetrahydrocannabinol +
dihydroergotamine mesylate
dihydroergotamine tartrate The L-(+)-tartaric acid salt of dihydroergotamine, a semisynthetic ergot alkaloid with weaker oxytocic and vasoconstrictor properties than ergotamine. Both the tartrate and the mesylate salts are used for the treatment of migraine and orthostatic hypotension.
fenfluramine hydrochloride +
lorcaserin hydrochloride +
lorcaserin hydrochloride hemihydrate
loxoprofen sodium hydrate
lysergic acid diethylamide +
N-methylquipazine dimaleate
nicotinyl alcohol tartrate
oxymetazoline hydrochloride
P(1),P(5)-bis(5'-adenosyl) pentaphosphate
P(1),P(6)-bis(5'-adenosyl)hexaphosphate
phenazopyridine hydrochloride
tetrahydrozoline hydrochloride
vortioxetine hydrobromide
|
|
|
Synonyms |
Exact Synonyms: |
Bis[(10alphaH)-5'alpha-benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman] (2R,3R)-2,3-dihydroxybutanedioate
|
Related Synonyms: |
9,10-dihydroergotamine (R,R)-tartrate
;
9,10-dihydroergotamine L-tartrate
;
9,10-dihydroergotamine tartrate
;
Formula=C70H80N10O16
;
InChI=1S/2C33H37N5O5.C4H6O6/c2*1-32(35-29(39)21-15-23-22-10-6-11-24-28(22)20(17-34-24)16-25(23)36(2)18-21)31(41)38-26(14-19-8-4-3-5-9-19)30(40)37-13-7-12-27(37)33(38,42)43-32;5-1(3(7)8)2(6)4(9)10/h2*3-6,8-11,17,21,23,25-27,34,42H,7,12-16,18H2,1-2H3,(H,35,39);1-2,5-6H,(H,7,8)(H,9,10)/t2*21-,23-,25-,26+,27+,32-,33+;1-,2-/m111/s1
;
InChIKey=AYYQJUDESMECLY-QCMZQTNXSA-N
;
SMILES=O[C@H]([C@@H](O)C(O)=O)C(O)=O.[H][C@@]12Cc3c[nH]c4cccc(c34)[C@@]1([H])C[C@H](CN2C)C(=O)N[C@]1(C)O[C@]2(O)N([C@@H](Cc3ccccc3)C(=O)N3CCC[C@@]23[H])C1=O.[H][C@@]12Cc3c[nH]c4cccc(c34)[C@@]1([H])C[C@H](CN2C)C(=O)N[C@]1(C)O[C@]2(O)N([C@@H](Cc3ccccc3)C(=O)N3CCC[C@@]23[H])C1=O
;
bis(5'alpha-benzyl-9,10alpha-dihydro-12'-hydroxy-2'-methylergotaman-3',6',18-trione) (R-(R*,R*))-tartrate
;
dihydroergotamine (R,R)-tartrate
;
dihydroergotamine L-tartrate
|
Xrefs: |
Beilstein:10757774
;
CAS:5989-77-5
;
KEGG:D07838 |
|